Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics: Part II. Strategies to reduce scar formation after dermatologic procedures

Journal of the American Academy of Dermatology

Volumn 66, Issue 1, 2012, Pages 13-24

  Tziotzios, Christos ^a   Profyris, Christos ^b   Sterling, Jane ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

antiscarring agents; cutaneous scar reduction strategies

Indexed keywords

ALPHA TOCOPHEROL; AVOTERMIN; BLEOMYCIN; BOTULINUM TOXIN A; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; FLUOROURACIL; IMIQUIMOD; INSULIN; MANNOSE 6 PHOSPHATE; METHOTREXATE; MITOMYCIN C; ONION EXTRACT; PLACEBO; RECOMBINANT INTERLEUKIN 10; RETINOIC ACID; SILICONE; TAMOXIFEN;

CRYOSURGERY; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HUMAN; INFLAMMATION; LOW LEVEL LASER THERAPY; MEDICAL RESEARCH; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SKIN SCAR; SKIN TENSION; UNSPECIFIED SIDE EFFECT; VACUUM ASSISTED CLOSURE; WOUND CLOSURE;

BANDAGES; CICATRIX; CICATRIX, HYPERTROPHIC; DERMATOLOGIC AGENTS; HUMANS; KELOID; RISK FACTORS; SKIN; WOUND HEALING;

EID: 83655190836     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.08.035     Document Type: Review

References (110)

1. G. Juckett, and H. Hartman-Adams Management of keloids and hypertrophic scars Am Fam Physician 80 2009 253 260
2. D. Leventhal, M. Furr, and D. Reiter Treatment of keloids and hypertrophic scars Arch Facial Plast Surg 8 2006 362 368
3. R. Ogawa Keloid and hypertrophic scarring may result from a mechanoreceptor or mechanosensitive nociceptor disorder Med Hypotheses 71 2008 493 500
4. S. Aarabi, K.A. Bhatt, Y. Shi, J. Paterno, E.I. Chang, and S.A. Loh Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis FASEB J 21 2007 3250 3261 (Pubitemid 47565543)
5. A.P. Kelly Keloids and hypertrophic scars L.C. Parish, G.P. Lask, Aesthetic Dermatology 1991 McGraw-Hill New York, NY 8 69
6. B. Berman, O.A. Perez, S. Konda, B.E. Kohut, M.H. Viera, and S. Delgado A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management Dermatol Surg 33 2007 1291 1303
7. J.A. Atkinson, K.T. McKenna, A.G. Barnett, D.J. McGrath, and M. Rudd A randomized, controlled trial to determine the efficacy of paper tape in preventing hypertrophic scar formation in surgical incisions that traverse Langer's skin tension lines Plast Reconstr Surg 116 2005 1648 1658
8. R.S. Reiffel Prevention of hypertrophic scars by long-term paper tape application Plast Reconstr Surg 96 1995 1715 1718
9. J. Wang, K. Hori, J. Ding, Y. Huang, P. Kwan, and A. Ladak Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring J Cell Physiol 226 2011 1265 1273
10. P. Coulthard, M. Esposito, H.V. Worthington, M. van der Elst, O.J. van Waes, and J. Darcey Tissue adhesives for closure of surgical incisions Cochrane Database Syst Rev 5 2010 CD004287
11. R.L. Moy, B. Waldman, and D.W. Hein A review of sutures and suturing techniques J Dermatol Surg Oncol 18 1992 785 795
12. U. Hohenleutner, N. Egner, S. Hohenleutner, and M. Landthaler Intradermal buried vertical mattress suture as sole skin closure: evaluation of 149 cases Acta Derm Venereol 80 2000 344 347 (Pubitemid 32014448)
13. T.J. Zuber The mattress sutures: vertical, horizontal, and corner stitch Am Fam Physician 66 2002 2231 2236 (Pubitemid 36193495)
14. R.P. Luck, R. Flood, D. Eyal, J. Saludades, C. Hayes, and J. Gaughan Cosmetic outcomes of absorbable versus nonabsorbable sutures in pediatric facial lacerations Pediatr Emerg Care 24 2008 137 142 (Pubitemid 351416867)
15. H. Karounis, S. Gouin, H. Eisman, D. Chalut, H. Pelletier, and B. Williams A randomized, controlled trial comparing long-term cosmetic outcomes of traumatic pediatric lacerations repaired with absorbable plain gut versus nonabsorbable nylon sutures Acad Emerg Med 11 2004 730 735 (Pubitemid 38844190)
16. G.J. Parell, and G.D. Becker Comparison of absorbable with nonabsorbable sutures in closure of facial skin wounds Arch Facial Plast Surg 5 2003 488 490
17. S. Durkaya, M. Kaptanoglu, A. Nadir, S. Yilmaz, Z. Cinar, and K. Dogan Do absorbable sutures exacerbate presternal scarring? Tex Heart Inst J 32 2005 544 548 (Pubitemid 43275790)
18. T. Al-Abdullah, A.C. Plint, and D. Fergusson Absorbable versus nonabsorbable sutures in the management of traumatic lacerations and surgical wounds: a meta-analysis Pediatr Emerg Care 23 2007 339 344 (Pubitemid 46788011)
19. F.B. Niessen, P.H. Spauwen, and M. Kon The role of suture material in hypertrophic scar formation: monocryl vs. vicryl-rapide Ann Plast Surg 39 1997 254 260 (Pubitemid 27415276)
20. R. Shih, J. Waltzman, and G.R. Evans Review of over-the-counter topical scar treatment products Plast Reconstr Surg 119 2007 1091 1095
21. L. O'Brien, and A. Pandit Silicon gel sheeting for preventing and treating hypertrophic and keloid scars Cochrane Database Syst Rev 1 2006 CD003826
22. P. Morganroth, A.C. Wilmot, and C. Miller Over-the-counter scar products for postsurgical patients: disparities between online advertised benefits and evidence regarding efficacy J Am Acad Dermatol 61 2009 e31 e47
23. T.A. Mustoe, R.D. Cooter, M.H. Gold, F.D. Hobbs, A.A. Ramelet, and P.G. Shakespeare International clinical recommendations on scar management Plast Reconstr Surg 110 2002 560 571 (Pubitemid 34815962)
24. M. McGrath Topical scar modification: help or hype? Aesthet Surg J 25 2005 304 306 (Pubitemid 40862480)
25. G. Puzey The use of pressure garments on hypertrophic scars J Tissue Viability 12 2002 11 15
26. A.P. Kelly Medical and surgical therapies for keloids Dermatol Ther 17 2004 212 218 (Pubitemid 38656914)
27. F. Ren, P. Grazianetti, M. Stella, G. Magliacani, C. Pezzuto, and M. Cannas Release and activation of matrix metalloproteinase-9 during in vitro mechanical compression in hypertrophic scars Arch Dermatol 138 2002 475 478 (Pubitemid 34290025)
28. A. Anzarut, J. Olson, P. Singh, B.H. Rowe, and E.E. Tredget The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis J Plast Reconstr Aesthet Surg 62 2009 77 84
29. W. Dorsch, E. Schneider, T. Bayer, W. Breu, and H. Wagner Antiinflammatory effects of onions: inhibition of chemotaxis of human polymorphonuclear leukocytes by thiosulfinates and cepaenes Int Arch Allergy Appl Immunol 92 1990 39 42 (Pubitemid 20359725)
30. R.K. Johri, U. Zutshi, L. Kameshwaran, and C.K. Atal Effect of quercetin and Albizzia saponins on rat mast cell Indian J Physiol Pharmacol 29 1985 43 46 (Pubitemid 15225809)
31. B. Pawlikowska-Pawlega, and A. Gawron Effect of quercetin on the growth of mouse fibroblast cells in vitro Pol J Pharmacol 47 1995 531 535 (Pubitemid 26034347)
32. Z.M. Ross, E.A. O'Gara, D.J. Hill, H.V. Sleightholme, and D.J. Maslin Antimicrobial properties of garlic oil against human enteric bacteria: evaluation of methodologies and comparisons with garlic oil sulfides and garlic powder Appl Environ Microbiol 67 2001 475 480 (Pubitemid 32044456)
33. K.T. Augusti Therapeutic values of onion (Allium cepa L.) and garlic (Allium sativum L.) Indian J Exp Biol 34 1996 634 640 (Pubitemid 126496487)
34. E.I. Elnima, S.A. Ahmed, A.G. Mekkawi, and J.S. Mossa The antimicrobial activity of garlic and onion extracts Pharmazie 38 1983 747 748 (Pubitemid 14204455)
35. J.W. Cho, S.Y. Cho, S.R. Lee, and K.S. Lee Onion extract and quercetin induce matrix metalloproteinase-1 in vitro and in vivo Int J Mol Med 25 2010 347 352
36. B.A. Jackson, and A.J. Shelton Pilot study evaluating topical onion extract as treatment for postsurgical scars Dermatol Surg 25 1999 267 269 (Pubitemid 29191310)
37. V.Q. Chung, L. Kelley, D. Marra, and S.B. Jiang Onion extract gel versus petrolatum emollient on new surgical scars: prospective double-blinded study Dermatol Surg 32 2006 193 197
38. E. Koc, E. Arca, B. Surucu, and Z. Kurumlu An open, randomized, controlled, comparative study of the combined effect of intralesional triamcinolone acetonide and onion extract gel and intralesional triamcinolone acetonide alone in the treatment of hypertrophic scars and keloids Dermatol Surg 34 2008 1507 1514
39. A. Campanati, A. Savelli, L. Sandroni, B. Marconi, A. Giuliano, and K. Giuliodori Effect of allium cepa-allantoin-pentaglycan gel on skin hypertrophic scars: clinical and video-capillaroscopic results of an open-label, controlled, nonrandomized clinical trial Dermatol Surg 36 2010 1439 1444
40. L.S. Baumann, and J. Spencer The effects of topical vitamin E on the cosmetic appearance of scars Dermatol Surg 25 1999 311 315 (Pubitemid 29191320)
41. M. Jenkins, J.W. Alexander, B.G. MacMillan, J.P. Waymack, and R. Kopcha Failure of topical steroids and vitamin E to reduce postoperative scar formation following reconstructive surgery J Burn Care Rehabil 7 1986 309 312 (Pubitemid 16010121)
42. O.A. Perez, M.H. Viera, J.K. Patel, S. Konda, S. Amini, and R. Huo A comparative study evaluating the tolerability and efficacy of two topical therapies for the treatment of keloids and hypertrophic scars J Drugs Dermatol 9 2010 514 518
43. N. Zampieri, V. Zuin, R. Burro, A. Ottolenghi, and F.S. Camoglio A prospective study in children: pre- and post-surgery use of vitamin E in surgical incisions J Plast Reconstr Aesthet Surg 63 2010 1474 1478
44. G. Fiori, F. Galluccio, F. Braschi, L. Amanzi, I. Miniati, and M.L. Conforti Vitamin E gel reduces time of healing of digital ulcers in systemic sclerosis Clin Exp Rheumatol 27 3 suppl. 54 2009 51 54
45. R. Fässler, T. Sasaki, R. Timpl, M.L. Chu, and S. Werner Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice Exp Cell Res 222 1996 111 116 (Pubitemid 26046577)
46. P. Pérez, A. Page, A. Bravo, M. Del Río, I. Giménez-Conti, and I. Budunova Altered skin development and impaired proliferative and inflammatory responses in transgenic mice overexpressing the glucocorticoid receptor FASEB J 15 2001 2030 2032
47. O. Stojadinovic, B. Lee, C. Vouthounis, S. Vukelic, I. Pastar, and M. Blumenberg Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation J Biol Chem 282 2007 4021 4034 (Pubitemid 47084434)
48. W.S. Wu, F.S. Wang, K.D. Yang, C.C. Huang, and Y.R. Kuo Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation J Invest Dermatol 126 2006 1264 1271 (Pubitemid 43997906)
49. T.S. Alster, and T.B. West Treatment of scars: a review Ann Plast Surg 39 1997 418 432 (Pubitemid 27433267)
50. Y.W. Tang Intra and postoperative steroid injections for keloids and hypertrophic scars Br J Plast Surg 45 1992 371 373
51. W. Manuskiatti, and R.E. Fitzpatrick Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments Arch Dermatol 138 2002 1149 1155 (Pubitemid 35025686)
52. M.A. Darzi, N.A. Chowdri, S.K. Kaul, and M. Khan Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study Br J Plast Surg 45 1992 374 379
53. F.B. Niessen, P.H. Spauwen, J. Schalkwijk, and M. Kon On the nature of hypertrophic scars and keloids: a review Plast Reconstr Surg 104 1999 1435 1458 (Pubitemid 29466295)
54. J.J. Shaffer, S.C. Taylor, and F. Cook-Bolden Keloidal scars: a review with a critical look at therapeutic options J Am Acad Dermatol 46 2 suppl understanding 2002 S63 S97
55. H.C. Maguire Jr. Treatment of keloids with triamcinolone acetonide injected intralesionally JAMA 192 1956 325 326
56. A. Asilian, A. Darougheh, and F. Shariati New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars Dermatol Surg 32 2006 907 915 (Pubitemid 44034368)
57. T.S. Alster Laser scar revision: comparison study of 585-nm pulsed dye laser with and without intralesional corticosteroids Dermatol Surg 29 2003 25 29
58. N.A. Chowdri, M. Masarat, A. Mattoo, and M.A. Darzi Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy Aust N Z J Surg 69 1999 655 659 (Pubitemid 29422139)
59. A.D. Widgerow, L.A. Chait, and R. Stals New innovations in scar management Aesthetic Plast Surg 24 2000 227 234 (Pubitemid 30448124)
60. N.W. Yii, and J.D. Frame Evaluation of cynthaskin and topical steroid in the treatment of hypertrophic scars and keloids Eur J Plast Surg 19 1996 162 165 (Pubitemid 26161447)
61. S. Nanda, and B.S. Reddy Intralesional 5-fluorouracil as a treatment modality of keloids Dermatol Surg 30 2004 54 57 (Pubitemid 38174030)
62. G. Kontochristopoulos, C. Stefanaki, A. Panagiotopoulos, K. Stefanaki, T. Argyrakos, and A. Petridis Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study J Am Acad Dermatol 52 3 pt 1 2005 474 479
63. J.W. de Waard, B.M. de Man, T. Wobbes, C.J. van der Linden, and T. Hendriks Inhibition of fibroblast collagen synthesis and proliferation by levamisole and 5-fluorouracil Eur J Cancer 34 1998 162 167 (Pubitemid 28123395)
64. M. Apikian, and G. Goodman Intralesional 5-fluorouracil in the treatment of keloid scars Australas J Dermatol 45 2004 140 143 (Pubitemid 38607932)
65. R.E. Fitzpatrick Treatment of inflamed hypertrophic scars using intralesional 5-FU Dermatol Surg 25 1999 224 232 (Pubitemid 29146991)
66. Y. Saray, and A.T. Güle Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study Int J Dermatol 44 2005 777 784 (Pubitemid 41301018)
67. F.F. Naeini, J. Najafian, and K. Ahmadpour Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars Dermatol Surg 32 2006 1023 1030
68. A. España, T. Solano, and E. Quintanilla Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures Dermatol Surg 27 2001 23 27 (Pubitemid 32107611)
69. T. Hendricks, M.F. Martens, C.M. Huyben, and T. Wobbes Inhibition of basal and TGF beta-induced fibroblast collagen synthesis by antineoplastic agents. Implications for wound healing Br J Cancer 67 1993 545 550 (Pubitemid 23077650)
70. H.N. Yeowell, M.K. Marshall, L.C. Walker, V. Ha, and S.R. Pinnell Regulation of lysyl oxidase mRNA in dermal fibroblasts from normal donors and patients with inherited connective tissue disorders Arch Biochem Biophys 308 1994 299 305 (Pubitemid 24172637)
71. I. Bodokh, and P. Brun Treatment of keloid with intralesional bleomycin [in French] Ann Dermatol Venereol 123 1996 791 794 (Pubitemid 27062076)
72. B. Berman, and H.C. Bieley Adjunct therapies to surgical management of keloids Dermatol Surg 22 1996 126 130 (Pubitemid 26069616)
73. L.H. Engrav, J.R. Gottlieb, S.P. Millard, M.D. Walkinshaw, D.M. Heimbach, and J.A. Marvin A comparison of intramarginal and extramarginal excision of hypertrophic burn scars Plast Reconstr Surg 81 1988 40 45
74. R.S. English, and P.D. Shenefelt Keloids and hypertrophic scars Dermatol Surg 25 1999 631 638 (Pubitemid 29383470)
75. C.C. Zouboulis Cryosurgery in dermatology Eur J Dermatol 8 1998 466 474 (Pubitemid 28474139)
76. Y. Har-Shai, M. Amar, and E. Sabo Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids Plast Reconstr Surg 111 2003 1841 1852 (Pubitemid 36532336)
77. Y. Har-Shai, E. Sabo, E. Rohde, M. Hayms, C. Assaf, and C.C. Zouboulis Intralesional cryosurgery markedly enhances the involution of recalcitrant auricular keloids: a new clinical approach supported by experimental studies Wound Repair Regen 14 2006 18 27
78. Y. Har-Shai, W. Brown, D. Labbé, A. Dompmartin, I. Goldine, and T. Gil Intralesional cryosurgery for the treatment of hypertrophic scars and keloids following aesthetic surgery Int J Lower Extrem Wounds 7 2008 169 175
79. K.K. Lee, K. Mehrany, and N.A. Swanson Surgical revision Dermatol Clin 23 2005 141 150 (Pubitemid 40037314)
80. K.C. Nowak, M. McCormack, and R.J. Koch The effect of superpulsed carbon dioxide laser energy on keloid and normal dermal fibroblast secretion of growth factors: a serum-free study Plast Reconstr Surg 105 2000 2039 2048 (Pubitemid 30244008)
81. A. Capon, and S. Mordon Can thermal lasers promote skin wound healing? Am J Clin Dermatol 4 2003 1 12 (Pubitemid 36078535)
82. F.M. Leclre, and S.R. Mordon Twenty-five years of active laser prevention of scars: what have we learned? J Cosmet Laser Ther 12 2010 227 234
83. T.S. Alster Improvement of erythematous and hypertrophic scars by the 585-nm flashlamp-pumped pulsed dye laser Ann Plast Surg 32 1994 186 190 (Pubitemid 24057134)
84. T.S. Alster, and C.M. Williams Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser Lancet 345 1995 1198 1200
85. C. Vrijman, A.M. van Drooge, C.E. Limpens, J.D. Bos, J.P. van der Veen, and P.I. Spuls Laser and intense pulsed light therapy for the treatment of hypertrophic scars: a systematic review Br J Dermatol 2011 Jun 28 [Epub ahead of print]
86. P.Y. Shih, H.H. Chen, C.H. Chen, H.S. Hong, and C.H. Yang Rapid recurrence of keloid after pulse dye laser treatment Dermatol Surg 34 2008 1124 1127
87. 2 and erbium: YAG lasers: preoperative, intraoperative, and postoperative considerations Plast Reconstr Surg 103 1999 619 634
88. D. Manstein, G.S. Herron, and R.K. Sink Non-ablative fractional laser: a new concept for cutaneous remodeling using microscopic patterns of thermal injury Lasers Surg Med 34 2004 426 438 (Pubitemid 38890753)
89. E. Tierney, B.H. Mahmoud, D. Srivastava, D. Ozog, and D.J. Kouba Treatment of surgical scars with nonablative fractional laser versus pulsed dye laser: a randomized controlled trial Dermatol Surg 35 2009 1172 1180
90. N. Botwood, C. Lewanski, and C. Lowdell The risks of treating keloids with radiotherapy Br J Radiol 72 1999 1222 1224 (Pubitemid 30028940)
91. W.B. Rockwell, I.K. Cohen, and H.P. Ehrlich Keloids and hypertrophic scars: a comprehensive review Plast Reconstr Surg 84 1989 827 837 (Pubitemid 19286117)
92. S. Luo, M. Benathan, W. Raffoul, R.G. Panizzon, and D.V. Egloff Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions Plast Reconstr Surg 107 2001 87 96 (Pubitemid 32039240)
93. K.S. Lee, J.B. Jung, Y.J. Ro, Y.W. Ryoo, O.B. Kim, and J.Y. Song Effects of x-irradiation on survival and extracellular matrix gene expression of cultured keloid fibroblasts J Dermatol Sci 8 1994 33 37 (Pubitemid 24237064)
94. T.L. Borok, M. Bray, I. Sinclair, J. Plafker, L. LaBirth, and C. Rollins Role of ionizing irradiation for 393 keloids Int J Radiat Oncol Biol Phys 15 1988 865 870
95. W. Wagner, M. Alfrink, O. Micke, U. Schäfer, P. Schüller, and N. Willich Results of prophylactic irradiation in patients with resected keloids - a retrospective analysis Acta Oncol 39 2000 217 220 (Pubitemid 30316891)
96. D.I. Klumpar, J.C. Murray, and M. Anscher Keloids treated with excision followed by radiation therapy J Am Acad Dermatol 31 1994 225 231 (Pubitemid 24242858)
97. R. Ragoowansi, P.G. Cornes, A.L. Moss, and J.P. Glees Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy Plast Reconstr Surg 111 2003 1853 1859 (Pubitemid 36532337)
98. G.A. Viani, E.J. Stefano, S.L. Afonso, and L.I. De Fendi Postoperative strontium-90 brachytherapy in the prevention of keloids: results and prognostic factors Int J Radiat Oncol Biol Phys 73 2009 1510 1516
99. M.W.J. Ferguson, J. Duncan, J. Bond, J. Bush, P. Durani, and K. So Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies Lancet 373 2009 1264 1274
100. US National Institutes of Health, ClinicalTrials.gov web site. A double blind, within patient, placebo controlled trial to assess the efficacy of Juvista (avotermin) in conjunction with scar revision surgery for the improvement of disfiguring scars. Available from: http://www.clinicaltrials.gov/ ct2/show/NCT00742443. Accessed February 16, 2010.
101. M.F. Cordeiro, A. Mead, R.R. Ali, R.A. Alexander, S. Murray, and C. Chen Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome Gene Ther 10 2003 59 71 (Pubitemid 36175827)
102. B.M. Choi, H.J. Kwak, C.D. Jun, S.D. Park, K.Y. Kim, and H.R. Kim Control of scarring in adult wounds using antisense transforming growth factor beta1 oligodeoxynucleotides Immunol Cell Biol 74 1996 144 150
103. US National Institutes of Health, ClinicalTrials.gov web site. A single-centre, placebo- and standard-care-controlled, double-blind, randomised trial to investigate the efficacy of eight doses of RN1003 in the reduction of scarring from the approximated wound margins of incisional wounds. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00984646. Accessed February 18, 2010.
104. US National Institutes of Health, ClinicalTrials.gov web site. An exploratory, single centre, randomized, placebo controlled, assessor blind clinical trial to assess the effects of intradermal administrations of Prevascar on scarring in human subjects of African continental ancestral origin. Available from: http://www.clinicaltrials.gov/ct2/show/NCT01115868. Accessed February 18, 2010.
105. US National Institutes of Health, ClinicalTrials.gov web site. A trial to investigate the clinical safety, local toleration, and systemic pharmacokinetics of repeated, escalating concentrations of intradermal RN1004 to wounds of healthy subjects. Available from: http://www.clinicaltrials.gov/ct2/ show/NCT00984854. Accessed February 18, 2010.
106. US National Institutes of Health, ClinicalTrials.gov web site. A double blind, placebo controlled trial to investigate the efficacy and safety of two concentrations of Juvidex (mannose-6-phosphate) in accelerating the healing of split thickness skin graft donor sites using different dosing regimes. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00664352. Accessed February 18, 2010.
107. Renovo Web site. Available from: URL: http://www.renovo.com/en/products/ juvidex. Accessed October 15, 2011.
108. R. Baker, N. Sojitra, A.O. Grobbelaar, and C. Linge A randomised controlled trial of the efficacy of insulin as an antiscarring agent J Plast Reconstr Aesthetic Surg 60 2007 S11
109. R. Baker, C. Vigor, J. Richardson, K. Rolfe, A. Grobbelaar, and C. Linge Potential mechanism of action of insulin as an anti-scarring agent J Plast Reconstr Aesthetic Surg 59 2006 S3 S4 [abstract]
110. M.H. Viera, S. Amini, W. Valins, and B. Berman Innovative therapies in the treatment of keloids and hypertrophic scars J Clin Aesthet Dermatol 3 2010 20 26